153 related articles for article (PubMed ID: 36989955)
1. The value of blood-based measures of liver function and urate in lung cancer risk prediction: A cohort study and health economic analysis.
Horsfall LJ; Clarke CS; Nazareth I; Ambler G
Cancer Epidemiol; 2023 Jun; 84():102354. PubMed ID: 36989955
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Lung Cancer Risk Prediction Model Incorporating Lung Function: Development and Validation in the UK Biobank Prospective Cohort Study.
Muller DC; Johansson M; Brennan P
J Clin Oncol; 2017 Mar; 35(8):861-869. PubMed ID: 28095156
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China.
Zhao Z; Wang Y; Wu W; Yang Y; Du L; Dong H
JAMA Netw Open; 2022 May; 5(5):e2213634. PubMed ID: 35608858
[TBL] [Abstract][Full Text] [Related]
5. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.
Li N; Tan F; Chen W; Dai M; Wang F; Shen S; Tang W; Li J; Yu Y; Cao W; Xu Y; Qin C; Zhao L; Zhu M; Guo L; Wu Z; Yang Z; Zheng Y; Chen H; Liu Y; Wei D; Dong D; Cao J; Zhang S; Yan S; Wang N; Du L; Shen H; Wu N; He J;
Lancet Respir Med; 2022 Apr; 10(4):378-391. PubMed ID: 35276087
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial.
Balekian AA; Tanner NT; Fisher JM; Silvestri GA; Gould MK
Ann Am Thorac Soc; 2016 Sep; 13(9):1568-74. PubMed ID: 27387658
[TBL] [Abstract][Full Text] [Related]
7. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.
Wei MN; Su Z; Wang JN; Gonzalez Mendez MJ; Yu XY; Liang H; Zhou QH; Fan YG; Qiao YL
Thorac Cancer; 2020 May; 11(5):1224-1232. PubMed ID: 32196998
[TBL] [Abstract][Full Text] [Related]
8. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
9. Determinants of impaired lung function and lung cancer prediction among never-smokers in the UK Biobank cohort.
Warkentin MT; Lam S; Hung RJ
EBioMedicine; 2019 Sep; 47():58-64. PubMed ID: 31495719
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of the cost-effectiveness of screening for lung cancer with low dose computed tomography.
Grover H; King W; Bhattarai N; Moloney E; Sharp L; Fuller L
Lung Cancer; 2022 Aug; 170():20-33. PubMed ID: 35700629
[TBL] [Abstract][Full Text] [Related]
11. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
[TBL] [Abstract][Full Text] [Related]
13. Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model.
Chien LH; Chen CH; Chen TY; Chang GC; Tsai YH; Hsiao CF; Chen KY; Su WC; Wang WC; Huang MS; Chen YM; Chen CY; Liang SK; Chen CY; Wang CL; Lee MH; Chung RH; Tsai FY; Hu JW; Katki HA; Chatterjee N; Chanock SJ; Rothman N; Lan Q; Yang PC; Chen CJ; Chang IS; Hsiung CA
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):452-459. PubMed ID: 31848206
[TBL] [Abstract][Full Text] [Related]
14. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
15. Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations.
Behr CM; Oude Wolcherink MJ; IJzerman MJ; Vliegenthart R; Koffijberg H
Pharmacoeconomics; 2023 Apr; 41(4):395-411. PubMed ID: 36670332
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review.
Puggina A; Broumas A; Ricciardi W; Boccia S
Eur J Public Health; 2016 Feb; 26(1):168-75. PubMed ID: 26370440
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
[TBL] [Abstract][Full Text] [Related]
18. Early detection of lung cancer in Czech high-risk asymptomatic individuals (ELEGANCE): A study protocol.
Lambert L; Janouskova L; Novak M; Bircakova B; Meckova Z; Votruba J; Michalek P; Burgetova A
Medicine (Baltimore); 2021 Feb; 100(5):e23878. PubMed ID: 33592843
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
